-+ 0.00%
-+ 0.00%
-+ 0.00%

LB Pharmaceuticals CFO Joseph M. Miller files initial beneficial ownership statement

PUBT·09/14/2026 20:16:05
Listen to the news
LB Pharmaceuticals CFO Joseph M. Miller files initial beneficial ownership statement
  • LB Pharmaceuticals named Joseph M. Miller as chief financial officer in an initial Form 3 insider filing dated 09/02/2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LB Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001746372-26-000005), on September 14, 2026, and is solely responsible for the information contained therein.